Drug
Sebelipase Alfa
Sebelipase Alfa: highest development phase Phase 2, developed by Alexion. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Alexion
Trials
| Drug | Phase | Indication |
|---|---|---|
| Sebelipase Alfa NCT02112994 | Phase 2 | Lysosomal Acid Lipase Deficiency |
Latest
No recent events.
Follow Sebelipase Alfa on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.